Huons, Daewon, and Boryeong did dramatic operation and had lots of expenses on distribution and management
Three domestic pharmaceutical companies are being competitive for the development generic lung cancer drug.
On 29th according to MFDS, there are three generic developing companies which have passed bioequivalence Test(BE Test) for gefinitib
Gefinitib is a main component of Iressa, and CKD, Ildo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
